Previous studies have implicated a role for miR-92a in other pathobiological processes including type 1 diabetes (T1D) (90, 91), neurogenesis (92), cancer (25, 64, 93), as well as TLR (94) and estrogen receptor signaling (95). This evidence concerns the gene ESR1 and type 1 diabetes mellitus.